Caption: 
SwRI’s Rhodium™ virtual screening tool recently evaluated more than 40 million drug compounds in a week, with help from Department of Defense supercomputers, to identify high-probability drugs that may have efficacy against the coronavirus with minimal adverse side effects. SwRI recently received a $1.9 million, one-year contract to support efforts to develop a COVID-19 treatment from the Henry M. Jackson Foundation for the Advancement of Military Medicine.